193 related articles for article (PubMed ID: 18570904)
1. [1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): emergence of two agents which lead to misuse].
Lecompte Y; Roussel O; Perrin M
Ann Pharm Fr; 2008 Mar; 66(2):85-91. PubMed ID: 18570904
[TBL] [Abstract][Full Text] [Related]
2. 'Party pill' drugs--BZP and TFMPP.
Antia U; Tingle MD; Russell BR
N Z Med J; 2009 Dec; 122(1307):55-68. PubMed ID: 20148045
[TBL] [Abstract][Full Text] [Related]
3. In vivo interactions between BZP and TFMPP (party pill drugs).
Antia U; Tingle MD; Russell BR
N Z Med J; 2009 Sep; 122(1303):29-38. PubMed ID: 19851418
[TBL] [Abstract][Full Text] [Related]
4. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
5. Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand.
Wilkins C; Sweetsur P; Girling M
Drug Alcohol Rev; 2008 Nov; 27(6):633-9. PubMed ID: 19378447
[TBL] [Abstract][Full Text] [Related]
6. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
Schep LJ; Slaughter RJ; Vale JA; Beasley DM; Gee P
Clin Toxicol (Phila); 2011 Mar; 49(3):131-41. PubMed ID: 21495881
[TBL] [Abstract][Full Text] [Related]
7. The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: results of a longitudinal, web-based study.
Sheridan J; Dong CY; Butler R; Barnes J
Int J Drug Policy; 2013 Sep; 24(5):412-22. PubMed ID: 23499366
[TBL] [Abstract][Full Text] [Related]
8. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
[TBL] [Abstract][Full Text] [Related]
9. Update on 1-benzylpiperazine (BZP) party pills.
Monteiro MS; Bastos Mde L; Guedes de Pinho P; Carvalho M
Arch Toxicol; 2013 Jun; 87(6):929-47. PubMed ID: 23685794
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic effects and their action mechanism of the major active components of party pill drugs.
Min CR; Kim MJ; Park YJ; Kim HR; Lee SY; Chung KH; Oh SM
Toxicol Lett; 2012 Nov; 214(3):339-47. PubMed ID: 23026265
[TBL] [Abstract][Full Text] [Related]
11. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: a case of effective industry self-regulation?
Wilkins C; Sweetsur P
Int J Drug Policy; 2010 Jan; 21(1):86-90. PubMed ID: 19359158
[TBL] [Abstract][Full Text] [Related]
12. Benzylpiperazine: a drug of abuse?
Johnstone AC; Lea RA; Brennan KA; Schenk S; Kennedy MA; Fitzmaurice PS
J Psychopharmacol; 2007 Nov; 21(8):888-94. PubMed ID: 17606471
[TBL] [Abstract][Full Text] [Related]
13. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
[TBL] [Abstract][Full Text] [Related]
14. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
Wood DM; Button J; Lidder S; Ramsey J; Holt DW; Dargan PI
J Med Toxicol; 2008 Dec; 4(4):254-7. PubMed ID: 19031377
[TBL] [Abstract][Full Text] [Related]
15. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
Fantegrossi WE; Winger G; Woods JH; Woolverton WL; Coop A
Drug Alcohol Depend; 2005 Feb; 77(2):161-8. PubMed ID: 15664717
[TBL] [Abstract][Full Text] [Related]
16. Toxicity from the recreational use of 1-benzylpiperazine.
Gee P; Gilbert M; Richardson S; Moore G; Paterson S; Graham P
Clin Toxicol (Phila); 2008 Nov; 46(9):802-7. PubMed ID: 18821145
[TBL] [Abstract][Full Text] [Related]
17. Partying on? Life after BZP-based party pills.
Green JA
N Z Med J; 2008 Oct; 121(1283):35-42. PubMed ID: 18841183
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector.
Bishop SC; McCord BR; Gratz SR; Loeliger JR; Witkowski MR
J Forensic Sci; 2005 Mar; 50(2):326-35. PubMed ID: 15813543
[TBL] [Abstract][Full Text] [Related]
19. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans.
Antia U; Tingle MD; Russell BR
J Forensic Sci; 2010 Sep; 55(5):1311-8. PubMed ID: 20533987
[TBL] [Abstract][Full Text] [Related]
20. Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.
Thompson I; Williams G; Caldwell B; Aldington S; Dickson S; Lucas N; McDowall J; Weatherall M; Robinson G; Beasley R
J Psychopharmacol; 2010 Sep; 24(9):1299-308. PubMed ID: 19329546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
